Related Experiment Video
Updated: Jul 7, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
[Mechanisms underlying endothelin-1 effects on myocardial function]
A F Leite-Moreira1, A Rocha-Sousa, C Pedrosa
1Serviço de Fisiologia da Faculdade de Medicina da Universidade do Porto Centro de Cirurgia Cardio-Torácica do Hospital de São João. amoreira@med.up.pt
Endothelin-1 (ET-1) enhances cardiac function through ETA receptors, partially involving the Na+/H+ exchanger. These effects are consistent across human and rabbit myocardium.
Area of Science:
- Cardiovascular Physiology
- Molecular Pharmacology
- Cardiac Electrophysiology
Context:
- Endothelin-1 (ET-1) exhibits potent vasoconstrictor and inotropic effects.
- Recent studies have highlighted ET-1's influence on intrinsic myocardial properties.
- The precise mechanisms underlying ET-1's myocardial actions require further elucidation.
Purpose:
- To investigate the mechanisms by which Endothelin-1 (ET-1) affects myocardial function.
- To determine the receptor subtypes and signaling pathways involved in ET-1's cardiac effects.
- To compare the myocardial actions of ET-1 in human and non-human models.
Summary:
- ET-1 (1 and 10 nM) significantly increased contractility and relaxation in isolated rabbit papillary muscles and human atrial trabecula.
- These effects were mediated by ETA receptors, as they were abolished by the ETA antagonist BQ-123.
- Partial reduction of ET-1's effects by the Na+/H+ exchanger inhibitor MIA suggests its involvement in the signaling pathway.
Impact:
- The findings reveal that ET-1's myocardial effects are primarily mediated via ETA receptor binding.
- The study demonstrates a partial dependence on Na+/H+ exchanger activation for ET-1's actions on cardiac function.
- Results indicate conserved mechanisms of ET-1 action on the myocardium across species, relevant for cardiovascular research.
Related Concept Videos
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Myocarditis I: Introduction
Heart Failure II: Pathophysiology

